Sequentify

Sequentify was founded in 2021, based on a technology developed by co-founders Tamir Biezuner and Tom Fleischer in Liran Shlush's laboratory. Sequentify enables rapid, cost-effective, and automated sequencing by providing DNA library preparation for next-generation sequencing (NGS) and AI software, democratizing genomics. Sequentify's NGS products, based on its proprietary InfiniSeq platform, include applications such as COVID-19 surveillance, cancer diagnostics, and carrier screening.